A Retrospective Reappraisal of Labetalol’s Hemodynamic Effects
Published online on August 23, 2025
Abstract
Journal of Pharmacy Practice, Volume 39, Issue 3, Page 179-183, June 2026.
Background:Labetalol is an adrenergic antagonist used to manage blood pressure. Current package labeling and drug databases describe intravenous (IV) labetalol’s hemodynamic effects to have an alpha-to-beta potency relationship of 1:7, denoting a ...
Background:Labetalol is an adrenergic antagonist used to manage blood pressure. Current package labeling and drug databases describe intravenous (IV) labetalol’s hemodynamic effects to have an alpha-to-beta potency relationship of 1:7, denoting a ...